ONVO VivoSim Labs Inc.


$ 2.44 $ -0.28 (-9.4 %)    

Friday, 31-Oct-2025 19:12:44 EDT
QQQ $ 629.16 $ 3.02 (0.48 %)
DIA $ 475.58 $ 0.66 (0.14 %)
SPY $ 681.80 $ 2.23 (0.33 %)
TLT $ 90.21 $ -0.27 (-0.3 %)
GLD $ 368.20 $ -2.01 (-0.54 %)
$ 2.7
$ 2.57
$ 2.28 x 29
$ 3.00 x 20
$ 2.35 - $ 2.95
$ 1.41 - $ 21.96
693,714
na
na
$ 1.40
na
TBD
na
na (na)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 organovo-has-received-a-notice-of-allowance-for-a-us-patent-titled-engineered-intestinal-tissue-and-uses-thereof

https://patentcenter.uspto.gov/applications/17695538/ifw/docs

 organovo-holdings-issues-2967144-additional-shares-through-warrant-exercises-and-at-the-market-stock-sales-raising-23m-in-gross-proceeds-bringing-total-outstanding-shares-to-20421617

Organovo Holdings, Inc. (NASDAQ:ONVO) ("Organovo" or the "Company"), a clinical stage biotechnology company foc...

 why-organovo-onvo-stock-is-skyrocketing

Organovo shares are trading higher by 246% Tuesday morning. The company announced that Eli Lilly is set to acquire its FXR prog...

 organovo-holdings-appoints-norman-staskey-as-president-cfo-and-principal-financial-officer-effective-december-30-2024-in-connection-with-resignation-of-tomas-hess---filing

On December 23, 2024, Hess, the Company's former President, Chief Financial Officer and Principal Financial Officer, notifi...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION